FIELD: medicine; ophthalmology.
SUBSTANCE: applied compositions contain corticosteroid Rimexolone in concentration 0.001 to 0.1% mass/vl.
EFFECT: effective treatment of dry eye syndrome is provided at minimum by-effects due to limited eye penetrability of agent.
19 cl, 4 dwg, 4 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF OCULAR SURFACE DAMAGE AND DRY EYE SYMPTOMS | 2019 |
|
RU2806212C2 |
| EYE DROPS FOR DRY EYE SYNDROME | 2011 |
|
RU2459615C1 |
| COMPOSITIONS AND METHODS FOR TREATING EYE DISORDERS | 2020 |
|
RU2795913C2 |
| COMPOUNDS FOR TREATING/PREVENTING INFLAMMATORY OPHTHALMIC DISEASES | 2011 |
|
RU2582609C2 |
| COMPOSITIONS AND METHODS OF TREATING EYE DISORDERS | 2019 |
|
RU2802365C2 |
| COMPOSITION FOR EFFECTIVE LIPID DELIVERY TO HUMAN TEAR FILM USING SALT-SENSITIVE EMULSION SYSTEM | 2012 |
|
RU2772357C2 |
| DRY EYE TREATMENT COMPOSITIONS | 2012 |
|
RU2651046C2 |
| COMPOSITIONS AND METHODS FOR EYE TREATMENT | 2019 |
|
RU2793736C2 |
| METHOD OF TREATING INFLAMMATIONS OF ANTERIOR EYE SEGMENT | 2013 |
|
RU2513597C1 |
| EYE DROPS FOR TREATING DRY EYE SYNDROME | 2006 |
|
RU2302231C1 |
